Cardiac Expression of Placental Growth Factor Predicts the Improvement of Chronic Phase Left Ventricular Function in Patients With Acute Myocardial Infarction
- 18 April 2006
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 47 (8) , 1559-1567
- https://doi.org/10.1016/j.jacc.2005.11.064
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Infarct Remodeling After Intracoronary Progenitor Cell Treatment in Patients With Acute Myocardial Infarction (TOPCARE-AMI)Circulation, 2003
- Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factorBlood, 2003
- Placenta growth factor activates monocytes and correlates with sickle cell disease severityBlood, 2003
- VEGFR-1–Selective VEGF Homologue PlGF Is ArteriogenicCirculation Research, 2003
- Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)Circulation, 2002
- Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-γ and migration of endothelial cells expressing Flt 1Oncogene, 1998
- Assignment of Vascular Endothelial Growth Factor (VEGF) and Placenta Growth Factor (PlGF) Genes to Human Chromosome 6p12–p21 and 14q24–q31 Regions, RespectivelyGenomics, 1996
- Localisation of Placenta Growth Factor (PlGF) in Human Term PlacentaGrowth Factors, 1996
- A Heparin-Binding Form of Placenta Growth Factor (PlGF-2) is Expressed in Human Umbilical Vein Endothelial Cells and in PlacentaGrowth Factors, 1993
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985